(Q40245563)

18 September 2017

1 reference

title

Osteoporosis. Approaching treatment with optimism (English)

1 reference

18 September 2017

0 references

Mallette LE

1

1 reference

PubMed ID

6752925

18 September 2017

language of work or name

English

0 references

publication date

1 November 1982

1 reference

18 September 2017

Postgraduate Medicine

1 reference

18 September 2017

72

1 reference

18 September 2017

5

1 reference

18 September 2017

271-278

1 reference

Involutional Osteopenia: Current Concepts

18 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1982.11716267

Involutional (physiologic) bone loss in women and the feasibility of preventing structural failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1982.11716267

Bone mineral content of the lumbar spine in normal and osteoporotic women: cross-sectional and longitudinal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1982.11716267

Bone-mineral estimation by computer-assisted transverse axial tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1982.11716267

Parathyroid Function in Primary Osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1982.11716267

Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1982.11716267

Effect of Estrogens and Calcium Carbonate on Bone Loss in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1982.11716267

Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1982.11716267

Cardiovascular risk and use of estrogens or estrogen-progestagen combinations. Stanford three-community study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1982.11716267

Effect of postmenopausal estrogen therapy on diastolic blood pressure and bodyweight

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1982.11716267

Estrogen Use and Cancer Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1982.11716267

Editorial: Risks and benefits of estrogen use

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1982.11716267

Noncontraceptive Estrogens and Abnormalities of Endometrial Proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1982.11716267

Estrogen use in postmenopausal women--costs, risks, and benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1982.11716267

Bone response to termination of oestrogen treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1982.11716267

Effects of oral therapy with calcium and vitamin D in primary osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1982.11716267

Prevention of involutional bone loss by exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1982.11716267

Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1982.11716267

10.1080/00325481.1982.11716267

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference

PubMed ID

6752925